Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection - PubMed (original) (raw)
Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection
Vera Junker et al. Eur J Pharmacol. 2002.
Abstract
Our previous studies established that induction of growth factor synthesis and neuroprotection by the beta(2)-adrenoceptor agonist clenbuterol in vitro and in vivo was associated with the activation of astrocytes, the major source of trophic factors in the brain. In the present study, we further investigated the specificity of beta(2)-adrenoceptor-mediated effects on astrocyte activation and neuroprotection. In mixed hippocampal cultures neuroprotection against glutamate-induced cell death by clenbuterol (1 microM) was blocked by the beta(1/2)-adrenoceptor antagonist propranolol and the specific beta(2)-adrenoceptor antagonists 1-[2,3-(Dihydro-7-methyl-1H-inden-4-yl)-oxy]-3-[(1-methylethyl)-amino]-2-butanol (ICI 118,551, 10 microM) and butoxamine (10 microM), while the beta(1)-adrenoceptor-selective antagonist metoprolol (10 microM) showed no effect. The beta(2)-adrenoceptor agonists clenbuterol (1-100 microM) and salmeterol (0.01-1 microM) induced profound morphological changes of cultured astrocytes which transformed into activated astroglia with pronounced dendrite-like processes. This phenomenon was blocked by butoxamine (1 mM) and propranolol (10 microM), but not by metoprolol (10 microM). However, similar morphological changes in astrocytes were also observed after stimulation of beta(1)-adrenoceptors by dobutamine (1-10 microM) and norepinephrine (1-10 microM). This effect was blocked by propranolol (10 microM) and metoprolol (10 microM) but not by butoxamine (1 mM), suggesting that stimulation of either beta(1)- or beta(2)-adrenoceptors was sufficient to induce activation of astrocytes. In addition, beta(1)-adrenoceptor stimulation by dobutamine (1-10 microM) protected hippocampal neurons against glutamate toxicity. In a model of focal cerebral ischemia in mice the cerebroprotective effect of clenbuterol (0.3 mg/kg) was blocked by propranolol (5 mg/kg) and butoxamine (5 mg/kg). Interestingly, the infarct size was reduced after co-treatment with clenbuterol (0.3 mg/kg) and metoprolol (5 mg/kg) as compared to clenbuterol treatment (0.3 mg/kg) alone. In conclusion, activation of astrocytes and neuroprotection can be achieved by stimulation of either beta(1)- or beta(2)-adrenoceptors in vitro, whereas in vivo neuroprotection is preferentially mediated through beta(2)-adrenoceptors.
Similar articles
- Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF.
Semkova I, Schilling M, Henrich-Noack P, Rami A, Krieglstein J. Semkova I, et al. Brain Res. 1996 Apr 22;717(1-2):44-54. doi: 10.1016/0006-8993(95)01567-1. Brain Res. 1996. PMID: 8738252 - Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia.
Culmsee C, Junker V, Thal S, Kremers W, Maier S, Schneider HJ, Plesnila N, Krieglstein J. Culmsee C, et al. Eur J Pharmacol. 2007 Dec 1;575(1-3):57-65. doi: 10.1016/j.ejphar.2007.07.066. Epub 2007 Aug 3. Eur J Pharmacol. 2007. PMID: 17869242 - NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study.
Culmsee C, Semkova I, Krieglstein J. Culmsee C, et al. Neurochem Int. 1999 Jul;35(1):47-57. doi: 10.1016/s0197-0186(99)00032-7. Neurochem Int. 1999. PMID: 10403429 - Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors.
Semkova I, Krieglstein J. Semkova I, et al. Brain Res Brain Res Rev. 1999 Aug;30(2):176-88. doi: 10.1016/s0165-0173(99)00013-2. Brain Res Brain Res Rev. 1999. PMID: 10525174 Review. - beta(2)-Adrenoceptors and ventricular fibrillation.
Altschuld RA, Billman GE. Altschuld RA, et al. Pharmacol Ther. 2000 Oct;88(1):1-14. doi: 10.1016/s0163-7258(00)00075-9. Pharmacol Ther. 2000. PMID: 11033381 Review.
Cited by
- Identification of isoxsuprine hydrochloride as a neuroprotectant in ischemic stroke through cell-based high-throughput screening.
Hill JW, Thompson JF, Carter MB, Edwards BS, Sklar LA, Rosenberg GA. Hill JW, et al. PLoS One. 2014 May 7;9(5):e96761. doi: 10.1371/journal.pone.0096761. eCollection 2014. PLoS One. 2014. PMID: 24804769 Free PMC article. - Astrocyte, a Promising Target for Mood Disorder Interventions.
Zhou X, Xiao Q, Xie L, Yang F, Wang L, Tu J. Zhou X, et al. Front Mol Neurosci. 2019 Jun 5;12:136. doi: 10.3389/fnmol.2019.00136. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31231189 Free PMC article. Review. - Increased beta(2)-adrenergic receptor activity by thyroid hormone possibly leads to differentiation and maturation of astrocytes in culture.
Ghosh M, Das S. Ghosh M, et al. Cell Mol Neurobiol. 2007 Dec;27(8):1007-21. doi: 10.1007/s10571-007-9202-9. Epub 2007 Sep 8. Cell Mol Neurobiol. 2007. PMID: 17828453 Free PMC article. - Role of β-adrenoceptors in glucose uptake in astrocytes using β-adrenoceptor knockout mice.
Catus SL, Gibbs ME, Sato M, Summers RJ, Hutchinson DS. Catus SL, et al. Br J Pharmacol. 2011 Apr;162(8):1700-15. doi: 10.1111/j.1476-5381.2010.01153.x. Br J Pharmacol. 2011. PMID: 21138422 Free PMC article. - Dose-effects of aorta-infused clenbuterol on spinal cord ischemia-reperfusion injury in rabbits.
Chen B, Zhang Y, Chen L, Huang S, Li S, Yao J. Chen B, et al. PLoS One. 2013 Dec 31;8(12):e84095. doi: 10.1371/journal.pone.0084095. eCollection 2013. PLoS One. 2013. PMID: 24391890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources